3种新型血管扩张剂治疗急性脑梗死的最小成本分析

杨文波a;申顺子b

引用本文:	杨文波a;申顺子b.3种新型血管扩张剂治疗急性脑梗死的最小成本分析[J].中国现代应用药学,2008,(5):458-460.
	YANG Wen-boa,SHEN Shun-zib.Cost-minimization Analysis of three New Vasodilators in Treating Acute Cerebral Infarction[J].Chin J Mod Appl Pharm(中国现代应用药学),2008,(5):458-460.

【打印本页】【HTML】【下载PDF全文】【查看/发表评论】【EndNote】【RefMan】【BibTex】

←前一篇|后一篇→

过刊浏览高级检索

本文已被：浏览 1766次下载 1340次	码上扫一扫！
分享到：微信更多字体:加大+\|默认\|缩小-
3种新型血管扩张剂治疗急性脑梗死的最小成本分析
杨文波a;申顺子b

作者	单位
杨文波a;申顺子b

摘要:

关键词: 急性脑梗死新型血管扩张剂最小成本分析

DOI：

分类号:

基金项目:

Cost-minimization Analysis of three New Vasodilators in Treating Acute Cerebral Infarction

YANG Wen-boa,SHEN Shun-zib

Abstract:

OBJECTIVE To compare the effects and costs of three new vasodilators(vinpocetine;buflomedil;cinepazide)combined with ozagrel in treating acute cerebral infarction(ACI).METHODS Cost-minimization analysis(CMA)of pharmacoeconomics was applied to analyze the

Key words: ACI New Vasodilators CMA